Nakao Kazuhito, Singh Mahendra, Sapkota Kiran, Hagler Bailey C, Hunter Robert N, Raman Chander, Hablitz John J, Nakazawa Kazu
Department of Neuroscience, Southern Research, Birmingham, AL, 35205, USA.
Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Neuropsychopharmacology. 2020 Dec;45(13):2207-2218. doi: 10.1038/s41386-020-00819-0. Epub 2020 Aug 28.
Cortical gamma oscillations are believed to be involved in mental processes which are disturbed in schizophrenia. For example, the magnitudes of sensory-evoked oscillations, as measured by auditory steady-state responses (ASSRs) at 40 Hz, are robustly diminished, whereas the baseline gamma power is enhanced in schizophrenia. Such dual gamma oscillation abnormalities are also present in a mouse model of N-methyl-D-aspartate receptor hypofunction (Ppp1r2cre/Grin1 knockout mice). However, it is unclear whether the abnormal gamma oscillations are associated with dysfunction in schizophrenia. We found that glycogen synthase kinase-3 (GSK3) is overactivated in corticolimbic parvalbumin-positive GABAergic interneurons in Grin1 mutant mice. Here we addressed whether GSK3β inhibition reverses both abnormal gamma oscillations and behavioral deficits with high correlation by pharmacological and genetic approach. We demonstrated that the paralog selective-GSK3β inhibitor, but not GSK3α inhibitor, normalizes the diminished ASSRs, excessive baseline gamma power, and deficits in spatial working memory and prepulse inhibition (PPI) of acoustic startle in Grin1 mutant mice. Cell-type specific GSK3B knockdown, but not GSK3A knockdown, also reversed abnormal gamma oscillations and behavioral deficits. Moreover, GSK3B knockdown, but not GSK3A knockdown, reverses the mutants' in vivo spike synchrony deficits. Finally, ex vivo patch-clamp recording from pairs of neighboring cortical pyramidal neurons showed a reduction of synchronous spontaneous inhibitory-postsynaptic-current events in mutants, which was reversed by GSK3β inhibition genetically and pharmacologically. Together, GSK3β inhibition in corticolimbic interneurons ameliorates the deficits in spatial working memory and PPI, presumably by restoration of synchronous GABA release, synchronous spike firing, and evoked-gamma power increase with lowered baseline power.
皮质γ振荡被认为参与了精神分裂症中受到干扰的心理过程。例如,通过40Hz听觉稳态反应(ASSRs)测量的感觉诱发振荡幅度在精神分裂症中显著降低,而基线γ功率则增强。这种双重γ振荡异常也存在于N-甲基-D-天冬氨酸受体功能减退的小鼠模型(Ppp1r2cre/Grin1基因敲除小鼠)中。然而,尚不清楚异常的γ振荡是否与精神分裂症的功能障碍有关。我们发现糖原合酶激酶-3(GSK3)在Grin1突变小鼠的皮质边缘小白蛋白阳性GABA能中间神经元中过度激活。在这里,我们通过药理学和遗传学方法探讨了GSK3β抑制是否能逆转异常的γ振荡和具有高度相关性的行为缺陷。我们证明,旁系同源物选择性GSK3β抑制剂而非GSK3α抑制剂可使Grin1突变小鼠中降低的ASSRs、过高的基线γ功率以及空间工作记忆和听觉惊吓前脉冲抑制(PPI)缺陷恢复正常。细胞类型特异性的GSK3B敲低而非GSK3A敲低也能逆转异常的γ振荡和行为缺陷。此外,GSK3B敲低而非GSK3A敲低可逆转突变体体内的峰同步缺陷。最后,对相邻皮质锥体神经元对进行的离体膜片钳记录显示,突变体中同步自发抑制性突触后电流事件减少,而通过基因和药理学方法抑制GSK3β可使其逆转。总之,皮质边缘中间神经元中的GSK3β抑制可改善空间工作记忆和PPI缺陷,可能是通过恢复同步GABA释放、同步峰发放以及在降低基线功率的情况下诱发γ功率增加来实现的。